AI assistant
HEALTHEQUITY, INC. — Director's Dealing 2016
Aug 24, 2016
30722_dirs_2016-08-24_fe715d2e-f605-4d68-b991-9a1b3b990052.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2016-08-22
Reporting Person: MOTT DARCY G (Executive VP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-22 | Common Stock | M | 14000 | $0.1 | Acquired | 80000 | Direct |
| 2016-08-22 | Common Stock | S | 9500 | $29.1161 | Disposed | 70500 | Direct |
| 2016-08-22 | Common Stock | S | 500 | $29.486 | Disposed | 70000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-22 | Stock Option (right to buy) | $0.1 | M | 14000 | Disposed | 2017-06-20 | Common Stock (14000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $14 | 2024-07-30 | Common Stock (10000) | 10000 | Direct |
| Stock Option (right to buy) | $0.1 | 2018-05-22 | Common Stock (20000) | 20000 | Direct |
| Stock Option (right to buy) | $1.25 | 2021-08-08 | Common Stock (125000) | 125000 | Direct |
| Stock Option (right to buy) | $25.39 | 2025-03-26 | Common Stock (25000) | 25000 | Direct |
Footnotes
F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.48 to $29.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.48 to $29.51, inclusive.
F4: The option is immediately exercisable.
F5: The option became exercisable as to 6,250 shares on March 26, 2016. The remaining shares become exercisable in three equal annual installments of 6,250 shares on March 26, 2017, 2018 and 2019.